Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
De Novo Lipogenesis of Sebaceous Glands in Acne
NCT02620813Phase 1Completed
- Sponsor
- University of California, Davis
- Start
- Oct 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of TMB-001 and tretinoin in acne vulgaris (3 arms), sponsored by University of California, Davis. Primary endpoints: Sebumeter measurement differences before and after treatment at 3 months and Change in the fractional contribution of DNL to the total sebum palmitate at 3 months. Started Oct 2015; status: completed.
02
Drugs
TMB-001tretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02620813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02620813.